The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 3
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
Cited by
Items 201–300 of 998
Drosophila melanogasteras a Model for Diabetes Type 2 Progression
Álvarez-Rendón, J. P., Salceda, R., & Riesgo‐Escovar, J. R. (2018) · BioMed Research International · doi:10.1155/2018/1417528 · Cited by 84
“However, in vertebrates, the eventual deterioration of beta cells leads to ultimate failure of this initial compensation [181].”
Backgroundvon Loeffelholz, C., Coldewey, S. M., & Birkenfeld, A. L. (2021) · Cells · doi:10.3390/cells10071822 · Cited by 73
“Of the lipotoxic intermediates responsible for impaired insulin signaling, the DNL and fatty acid esterification product diacylglycerol represents an extraordinary candidate [14,109,118].”
BackgroundHypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease
Lefere, S., Steenkiste, C. V., Verhelst, X., Vlierberghe, H. V., Devisscher, L., & Geerts, A. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2222-1 · Cited by 77
“The resultant release of fatty acids into the bloodstream leads to re-esterification and deposition of fatty acids in insulin-sensitive organs such as the liver, causing both insulin resistance and NAFLD [20, 21].”
BackgroundPancreatic islet inflammation: an emerging role for chemokines
Collier, J. J., Sparer, T. E., Karlstad, M. D., & Burke, S. J. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0042 · Cited by 73
“2015) and T2D (Kahn 1998, Samuel & Shulman 2016).”
Triglycerides and glucose index as an insulin resistance marker in a sample of healthy adults
Toro-Huamanchumo, C. J., Urrunaga‐Pastor, D., Guarnizo-Poma, M., Lázaro-Alcántara, H., Paico-Palacios, S., Pantoja-Torres, B., Ranilla-Seguin, V. D. C., & Benites-Zapata, V. A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.09.010 · Cited by 80
Carresi, C., Gliozzi, M., Musolino, V., Scicchitano, M., Scarano, F., Bosco, F., Nucera, S., Maiuolo, J., Macrì, R., Ruga, S., et al. (2020) · Nutrients · doi:10.3390/nu12051504 · Cited by 77
“With an impaired hepatic metabolism of cholesterol and excess circulating FFAs, gluconeogenesis is increased leading to hyperglycemia [18].”
BackgroundMueller, K. M., Hartmann, K., Kaltenecker, D., Vettorazzi, S., Bauer, M., Mauser, L., Amann, S., Jall, S., Fischer, K., Esterbauer, H., et al. (2017) · Diabetes · doi:10.2337/db16-0381 · Cited by 66
“As NEFA/lipid accumulation can cause deleterious effects on insulin-sensitive organs (6), and inhibition of lipolysis improves systemic glucose metabolism (34,35), the attenuated adiposity and reduced lipolytic capacity are conceivable possibilities for the ameliorated glucose tolerance in GR mice.”
BackgroundInfluentialMechanism by which arylamine N -acetyltransferase 1 ablation causes insulin resistance in mice
Camporez, J. P., Wang, Y., Faarkrog, K., Chukijrungroat, N., Petersen, K. F., & Shulman, G. I. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716990115 · Cited by 66
“Increased DAG content in liver and skeletal muscle has been shown to play a causal role in liver and muscle insulin resistance by activation of PKCe in liver and PKCθ in skeletal muscle, leading to inhibition of insulin signaling at the level of the insulin receptor kinase (IRK) in liver (17–19) and at the level of in…”
BackgroundSelf-citationSebastiano, K. M. D., Pinthus, J. H., Duivenvoorden, W., & Mourtzakis, M. (2018) · Obesity Reviews · doi:10.1111/obr.12674 · Cited by 69
Zhong, J., Gong, W., Chen, J., Qing, Y., Shu-yue, W., Li, H., Huang, C., Chen, Y., Wang, Y., Xu, Z.-Z., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.036 · Cited by 66
Hydrogen Therapy in Cardiovascular and Metabolic Diseases: from Bench to Bedside
Zhang, Y., Tan, S., Xu, J., & Wang, T. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489737 · Cited by 68
Li, H., Zhang, Y., Luo, H., & Lin, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.977625 · Cited by 79
Mechanism for leptin’s acute insulin-independent effect to reverse diabetic ketoacidosis
Perry, R. J., Peng, L., Abulizi, A., Kennedy, L., Cline, G. W., & Shulman, G. I. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88477 · Cited by 65
Self-citationFatty liver and FGF21 physiology
Maratos–Flier, E. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.05.006 · Cited by 74
Role of Endoplasmic Reticulum-Mitochondria Communication in Type 2 Diabetes
Rieusset, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_13 · Cited by 68
“accumulation, mitochondrial dysfunction, oxidative stress, ER stress, and inflammation (Samuel and Shulman 2016).”
InfluentialCeramides and diabetes mellitus: an update on the potential molecular relationships
Yaribeygi, H., Bo, S., Ruscica, M., & Sahebkar, A. (2019) · Diabetic Medicine · doi:10.1111/dme.13943 · Cited by 66
Leptin Increases Hepatic Triglyceride Export via a Vagal Mechanism in Humans
Metz, M., Beghini, M., Wolf, P. S., Pfleger, L., Hackl, M. T., Bastian, M., Freudenthaler, A., Harreiter, J., Zeyda, M., Baumgartner-Parzer, S. M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.020 · Cited by 69
Prediabetes in youths: mechanisms and biomarkers
Weiss, R., Santoro, N., Giannini, C., Galderisi, A., Umano, G. R., & Caprio, S. (2017) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(17)30044-5 · Cited by 63
Protein Kinase C Epsilon Deletion in Adipose Tissue, but Not in Liver, Improves Glucose Tolerance
Brandon, A. E., Liao, B. M., Diakanastasis, B., Parker, B. L., Raddatz, K., McManus, S. A., O'Reilly, L., Kimber, E., van der Kraan, A. G., Hancock, D., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.013 · Cited by 63
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
“This may be due to an imbalance of regulatory adipokines and cytokines from increased VAT levels and circulating lipids leading to a decreased/delayed stimulus of the PI3K/Akt signalling cascade in response to glucose ingestion, as also observed in T2D individuals [119].”
BackgroundNutrition and Lifestyle Interventions in Managing Dyslipidemia and Cardiometabolic Risk
Berisha, H., Hattab, R., Comi, L., Giglione, C., Migliaccio, S., & Magni, P. (2025) · Nutrients · doi:10.3390/nu17050776 · Cited by 94
Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice
Kaltenecker, D., Mueller, K. M., Benedikt, P., Feiler, U., Themanns, M., Schlederer, M., Kenner, L., Schweiger, M., Haemmerle, G., & Moriggl, R. (2017) · Diabetologia · doi:10.1007/s00125-016-4152-8 · Cited by 62
Mitophagy in Hepatic Insulin Resistance: Therapeutic Potential and Concerns
Su, Z., Nie, Y., Huang, X., Zhu, Y., Feng, B. C., Tang, L., & Zheng, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01193 · Cited by 66
Tegegne, B. A., Adugna, A., Yenet, A., Yihunie Belay, W., Yibeltal, Y., Dagne, A., Hibstu Teffera, Z., Amare, G. A., Abebaw, D., Tewabe, H., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1440456 · Cited by 61
Food intake regulation by leptin: Mechanisms mediating gluconeogenesis and energy expenditure
Hussain, Z., & Khan, J. A. (2017) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2017.09.003 · Cited by 76
Perry, R. J., Peng, L., Cline, G. W., Butrico, G. M., Wang, Y., Zhang, X.-M., Rothman, D. L., Petersen, K. F., & Shulman, G. I. (2017) · Nature Communications · doi:10.1038/s41467-017-01143-w · Cited by 60
Self-citationThe sedentary (r)evolution: Have we lost our metabolic flexibility?
Freese, J., Klement, R. J., Ruiz-Núñez, B., Schwarz, S., & Lötzerich, H. (2018) · F1000Research · doi:10.12688/f1000research.12724.2 · Cited by 61
“However, as a consequence of prolonged insulin resistance, insulin receptors are blunted and transmembrane signaling is attenuated 197–199 .”
Kessler, K., Hornemann, S., Petzke, K. J., Kemper, M., Kramer, A., Pfeiffer, A. F. H., Pivovarova, O., & Rudovich, N. (2017) · Scientific Reports · doi:10.1038/srep44170 · Cited by 60
Dogra, S., Kar, A. K., Girdhar, K., Daniel, P. V., Chatterjee, S., Choubey, A., Ghosh, S., Patnaik, S., Ghosh, D., & Mondal, P. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.01.013 · Cited by 62
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Maevskaya, M. V., Kotovskaya, Y. V., Ivashkin, V. T., Ткачева, О. Н., Troshina, E. A., Shestakova, M. V., Breder, V. V., Geyvandova, N. I., Doshchitsin, V. L., Dudinskaya, Е. N., et al. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.02.201363 · Cited by 70
Huang, Y., Zhou, J. H., Zhang, H., Canfrán‐Duque, A., Singh, A. K., Perry, R. J., Shulman, G. I., Fernandez-Hernando, C. F., & Wang, M. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148852 · Cited by 67
“1172/JCI148852 Since skeletal muscle, liver, and ingWAT are 3 organs crucial for glucose metabolism and targets of insulin (36), we determined the expression of genes involving glucose uptake and glycolysis in these tissues.”
BackgroundSelf-citationMłynarska, E., Bojdo, K., Bulicz, A., Frankenstein, H., Gąsior, M., Kustosik, N., Rysz, J., & Franczyk, B. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100787 · Cited by 106
“However, selective impairment of IRS-PI3K-Akt signaling leads to reduced glucose disposal in muscle, enhanced lipolysis in WAT, and excessive gluconeogenesis in the liver, driving systemic IR [90,91,97,98].”
InfluentialJi, H., Liu, Y., He, F., An, R., & Du, Z. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.04.015 · Cited by 62
Luo, P., Zheng, M., Rui, Z., Zhang, H., Liu, Y., Li, W., Sun, X., Yu, Q., Tipoe, G. L., & Xiao, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.11.006 · Cited by 65
Li, W., Zeng, H., Xu, M., Huang, C., Tao, L., Li, J., Zhang, T., Chen, H., Xia, J., Li, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.697483 · Cited by 67
“For example, macrophage infiltration into WAT leads to up-regulation of lipolysis (Samuel and Shulman, 2016), resulting in an increase of free fatty acid (FFA) and consequently reactive oxygen species (ROS) overproduction (Hurrle and Hsu, 2017).”
BackgroundSevere Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment
Chung, L. Y., & Rhie, Y. (2021) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes21063 · Cited by 74
Ageing of skeletal muscle extracellular matrix and mitochondria: finding a potential link
Cai, L., Shi, L., Peng, Z., Sun, Y., & Chen, J. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2240707 · Cited by 71
“Sarcopenia, it is a systemic aggregation metabolic disorders from multiple causes, a vicious cycle formed between reduced physical activity/ sarcopenia – insulin resistance – inflammation/oxidative stress – lipotoxicity [78–80], a process of the metabaging cycle [81].”
BackgroundChen, M. Z., Chang, J. C., Zavala-Solorio, J., Kates, L., Thai, M., Ogasawara, A., Bai, X., Flanagan, S., Nunez, V., Phamluong, K., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.09.003 · Cited by 58
Wood, J., Tse, M. C. L., Yang, X., Brobst, D. E., Liu, Z., Pang, B. P. S., Chan, W. S., Zaw, A. M., Chow, B., Ye, K., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.06.007 · Cited by 59
Therapeutic Mechanisms of Herbal Medicines Against Insulin Resistance: A Review
Li, J., Bai, L., Wei, F., Zhao, J., Wang, D., Xiao, Y., Yan, W., & Wei, J. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00661 · Cited by 64
Milosevic, N. P., Milanović, M., Sudji, J., Bosić-Živanović, D., Stojanoski, S., Vuković, B., Milić, N., & Medic‐Stojanoska, M. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-06831-2 · Cited by 63
Jeremiah, K., Filteau, S., Faurholt‐Jepsen, D., Kitilya, B., Kavishe, B. B., Krogh‐Madsen, R., Olsen, M. F., Changalucha, J. M., Rehman, A. M., Range, N. S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230723 · Cited by 66
“Although diabetes or prediabetes risk persists during ART, our observation that it is only apparent by HbA1c suggests that during ART, hepatic insulin resistance may be a driver of hyperglycemia, possibly due to liver fat accumulation or other adverse effects of ART drugs [38, 39].”
BackgroundMoon, J. H., Koo, B. K., & Kim, W. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12719 · Cited by 55
Zhang, P., Konja, D., Zhang, Y., & Wang, Y. (2021) · Cells · doi:10.3390/cells10092195 · Cited by 61
Lee, H., Ha, T. Y., Jung, C. H., Nirmala, F. S., Park, S., Huh, Y. H., & Ahn, J. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12794 · Cited by 60
“Insulin resistance (IR) is characterized by the inability of tissues to respond appropriately to insulin.(1) Intake of foods high in fat and sugar can cause caloric excess that drives obesity, IR, and OR IG INAL ART ICLE”
BackgroundBiomarkers of dysfunctional visceral fat
Gugliucci, A. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.03.001 · Cited by 73
Huang, Y., Li, Z., & Yin, X. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02193-3 · Cited by 56
“TyG-i encapsulates the state of glucose metabolism, inflammatory processes, and oxidative stress [37] and mirrors glycosylation end-product metabolism and platelet activity, potentially leading to endothelial cell-dependent vasodilation.”
BackgroundRECOGNITION AND AVOIDANCE OF ION SOURCE‐GENERATED ARTIFACTS IN LIPIDOMICS ANALYSIS
Hu, C., Luo, W., Xu, J., & Han, X. (2020) · Mass Spectrometry Reviews · doi:10.1002/mas.21659 · Cited by 61
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript the form of TAG species (Nascimento-Ferreira et al., 2017; Samuel & Shulman, 2016).”
BackgroundMatboli, M., Saad, M., Hasanin, A. H., Saleh, L. A., Baher, W., Bekhet, M. M., & Eissa, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111176 · Cited by 63
Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases
Rieusset, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.01.001 · Cited by 64
Grace, M. S., Dempsey, P. C., Sethi, P., Mundra, P. A., Mellett, N. A., Weir, J. M., Owen, N., Dunstan, D. W., Meikle, P. J., & Kingwell, B. A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3926 · Cited by 54
Dziewulska, A., Dobosz, A. M., Dobrzyń, A., Smolinska, A., Kolczyńska, K., Ntambi, J. M., & Dobrzyń, P. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29026 · Cited by 55
“Changes in lipid metabolism often lead to alterations in insulin sensitivity in skeletal muscle (Samuel & Shulman, 2016).”
BackgroundHu, F., Tong, J., Deng, B., Zheng, J., & Lu, C. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02316-w · Cited by 55
Yang, Y., Zhang, J., & Zhou, Q. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1835819 · Cited by 60
Safina, D., Schlitt, F., Romeo, R., Pflanzner, T., Pietrzik, C. U., Narayanaswami, V., Edenhofer, F., & Faissner, A. (2016) · Glia · doi:10.1002/glia.23009 · Cited by 54
Sánchez‐González, C., Nuevo‐Tapioles, C., Martín, J. C. H., Pereira, M. P., Sanz, S. S., de Molina, A. R., Cuezva, J. M., & Formentini, L. (2020) · The EMBO Journal · doi:10.15252/embj.2019103812 · Cited by 60
“In oxidative Skm, reciprocal cross-talk between glucose and FA metabolism determines fuel selection through the Randle cycle (Samuel & Shulman, 2016).”
Salunkhe, S. A., Chitkara, D., Mahato, R. I., & Mittal, A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.003 · Cited by 57
Liang, D., Liu, C., & Wang, Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02248-5 · Cited by 56
“This impairment of nitric oxide function contributes to endothelial dysfunction, promotes smooth muscle cell proliferation, and results in collagen deposition [18, 46–48].”
BackgroundLu, Y., Jiang, Z., Dai, H., Miao, R., Shu, J., Gu, H., Liu, X., Huang, Z., Yang, G., Chen, A. F., et al. (2017) · Hepatology · doi:10.1002/hep.29633 · Cited by 54
“IRS-1 and PPARc,((20-22)) inflammation also exacerbates hepatic lipid accumulation by rendering an imbalance of lipid flux.((23,24)) In turn, impaired insulin sensitivity and fatty acid metabolic homeostasis aggravates inflammatory responses in the liver and the whole system.”
BackgroundRole of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Nagappan, A., Shin, J., & Jung, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092109 · Cited by 59
“Insulin resistance is a pathological condition, in which the cells do not respond to the insulin hormone [1,2].”
BackgroundInfluentialMizunoe, Y., Kobayashi, M., Tagawa, R., Nakagawa, Y., Shimano, H., & Higami, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153688 · Cited by 61
“Such accumulated ectopic lipid provokes insulin resistance in skeletal muscle and liver, leading to type 2 diabetes, fatty liver and heart disease [98,99].”
BackgroundMetabolic syndrome and its association with nonalcoholic steatohepatitis
Bril, F., Sanyal, A., & Cusi, K. (2023) · Clinics in Liver Disease · doi:10.1016/j.cld.2023.01.002 · Cited by 52
Mechanisms linking gut microbial metabolites to insulin resistance
Jang, H. R., & Lee, H. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.730 · Cited by 56
Accili, D. (2018) · Diabetes · doi:10.2337/dbi18-0025 · Cited by 55
“Since its introduction in the literature, insulin resistance has stood the test of time as a necessary predisposing factor to diabetes, even as its definition continues to evolve (3).”
BackgroundXie, E., Ye, Z., Wu, Y., Zhao, X., Li, Y., Shen, N., Gao, Y., & Zheng, J. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02028-7 · Cited by 56
The current state of GPCR‐based drug discovery to treat metabolic disease
Sloop, K. W., Emmerson, P. J., Statnick, M. A., & Willard, F. S. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14157 · Cited by 51
“Adiposity raises intracellular lipid content and intermediate metabolites such as DAG, acetyl-CoA, and various ceramides, which are associated with the development of insulin resistance (Samuel and Shulman, 2016).”
BackgroundUncaria tomentosa improves insulin sensitivity and inflammation in experimental NAFLD
Araujo, L. C. C., Feitosa, K. B., Murata, G. M., Furigo, I. C., Teixeira, S. A., Lucena, C. F., Ribeiro, L. M., Muscará, M. N., Costa, S. K. P., Donato, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29044-y · Cited by 63
TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
Hwang, J.-H., Kim, A. R., Kim, K. M., Park, J. I., Oh, H. T., Moon, S. A., Byun, M. R., Jeong, H., Kim, H. K., Yaffe, M. B., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08287-x · Cited by 58
Xu, M., Ge, C., Qin, Y., Gu, T.-T., Lv, J., Wang, S., Ma, Y., Lou, D., Li, Q., Hu, L., et al. (2019) · Food & Function · doi:10.1039/c8fo01615a · Cited by 52
Wang, A., Fan, W., Yang, T., He, S., Yang, Y., Yu, M., Fan, L., Zhu, Q., Guo, S., Zhu, C., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910168 · Cited by 55
High‐fat diet‐induced adipose tissue expansion occurs prior to insulin resistance in C57BL/6J mice
He, M., Wang, J., Wang, Y., Sui, J., Zhang, M., Ding, X., Yang, Z., Chen, Z., Ren, X., & Shi, B. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.06.003 · Cited by 55
“It has been proven that metabolic inflammation may impair insulin signaling in insulintargeted tissues and disrupt cellular metabolism.(4) However, the temporal features and the progression of metabolic inflammation and dysfunction in high-fat diet (HFD)-induced obesity patients remain unclear.”
BackgroundMitochondrial fat oxidation is essential for lipid-induced inflammation in skeletal muscle in mice
Warfel, J. D., Bermudez, E. M., Mendoza, T. M., Ghosh, S., Zhang, J., Elks, C. M., Mynatt, R., & Vandanmagsar, B. (2016) · Scientific Reports · doi:10.1038/srep37941 · Cited by 50
Effects of metformin on blood and urine pro-inflammatory mediators in patients with type 2 diabetes
Chen, W., Liu, X., & Ye, S. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0142-3 · Cited by 55
“Numerous pathogenic processes are implicated in the development of diabetes, which result from the β-cell destruction in the pancreas leading to insulin deficiency or from the abnormalities that cause insulin resistance in target tissues [1, 2].”
Nielsen, J., Christensen, A. E., Nellemann, B., & Christensen, B. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00062.2017 · Cited by 62
“IN SKELETAL MUSCLE, accumulation of lipid droplets (LDs) is associated with insulin resistance (15, 37, 39).”
BackgroundLi, L., Martin-Levilain, J., Jiménez‐Sánchez, C., Karaca, M., Foti, M., Martinou, J., & Maechler, P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007601 · Cited by 52
“Because the liver has a prominent metabolic activity largely relying on mitochondria, any dysfunction of this organelle may lead to metabolic alterations (52).”
BackgroundLiver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 54
Regulation of Energy Metabolism by Receptor Tyrosine Kinase Ligands
Zhao, M., Jung, Y., Jiang, Z., & Svensson, K. J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00354 · Cited by 60
Huang, J., Zhao, J., Geng, X., Chu, W., Li, S., Chen, Z., & Du, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.008 · Cited by 55
“Glucose uptake is activated via the canonical IRS-mediated GLUT4 vesicle translocation to themembrane.(69) In the present study, we found that increased CCNL led to decreased glucose uptake along with IRS1 and GLUT4 abundance.”
BackgroundInsulin Resistance and High Blood Pressure: Mechanistic Insight on the Role of the Kidney
Brosolo, G., Porto, A. D., Bulfone, L., Vacca, A., Bertin, N., Scandolin, L., Catena, C., & Sechi, L. A. (2022) · Biomedicines · doi:10.3390/biomedicines10102374 · Cited by 66
“Insulin resistance identifies any condition in which the response of metabolic target tissues, namely, skeletal muscle, fat, and liver, to normal circulating levels of insulin is impaired [12].”
BackgroundDall’Agnese, A., Platt, J. M., Zheng, M., Friesen, M., Dall’Agnese, G., Blaise, A. M., Spinelli, J. B., Henninger, J. E., Tevonian, E. N., Hannett, N. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35176-7 · Cited by 53
Ribel-Madsen, A., Ribel‐Madsen, R., Brøns, C., Newgard, C. B., Vaag, A. A., & Hellgren, L. I. (2016) · Physiological Reports · doi:10.14814/phy2.12977 · Cited by 54
Retinol saturase coordinates liver metabolism by regulating ChREBP activity
Heidenreich, S., Witte, N., Weber, P., Göhring, I., Tolkachov, A., von Loeffelholz, C., Döcke, S., Bauer, M. W., Stockmann, M., Pfeiffer, A. F. H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00430-w · Cited by 56
Body composition and cardiometabolic health: the need for novel concepts
Bosy‐Westphal, A., Braun, W., Geisler, C., Norman, K., & Müller, M. J. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0158-2 · Cited by 60
“lipid delivery to muscle cell exceeds lipid oxidation [22].”
BackgroundInfluentialDe novo lipogenesis is essential for platelet production in humans
Kelly, K. L., Reagan, W. J., Sonnenberg, G. E., Clasquin, M. F., Hales, K. J., Asano, S. M., Amor, P. A., Carvajal‐Gonzalez, S., Shirai, N., Matthews, M. D., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00272-9 · Cited by 50
Li, Q.-M., Zha, X., Zhang, W.-N., Liu, J., Pan, L., & Luo, J. (2021) · Food & Function · doi:10.1039/d0fo02100h · Cited by 48
Iheagwam, F. N., Iheagwam, O. T., Onuoha, M. K., Ogunlana, O. O., & Chinedu, S. N. (2022) · Scientific Reports · doi:10.1038/s41598-022-15114-9 · Cited by 59
Ballestri, S., Nascimbeni, F., Romagnoli, D., Baldelli, E., Targher, G., & Lonardo, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030355 · Cited by 50
Zheng, J., Zhang, Q., Mul, J. D., Yu, M., Xu, J., Qi, C., Wang, T., & Xiao, X. (2016) · Endocrine · doi:10.1007/s12020-016-0959-9 · Cited by 48
Wesolowski, S. R., Mulligan, C. M., Janssen, R. C., Baker, P. R., Bergman, B. C., D’Alessandro, A., Nemkov, T. G., Maclean, K. N., Jiang, H., Dean, T. A., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.008 · Cited by 51
“Thus, metabolic fuel overload in utero might interrupt normal development of metabolic pathways that accelerate NAFLD risk in the next generation [32,33].”
BackgroundMarkova, M., Koelman, L., Hornemann, S., Pivovarova, O., Sucher, S., Machann, J., Rudovich, N., Thomann, R., Schneeweiss, R., Rohn, S., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.03.019 · Cited by 47
Obesity- and lipid-related indices as a predictor of type 2 diabetes in a national cohort study
Wang, Y., Zhang, X., Li, Y., Gui, J., Mei, Y., Yang, X., Liu, H., Guo, L., Li, J., Lei, Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1331739 · Cited by 58
Xiao, S., Zhang, Q., Yang, H.-Y., Tong, J.-Y., & Yang, R. (2024) · Scientific Reports · doi:10.1038/s41598-024-63886-z · Cited by 49
“In addition, the levels of free fatty acids (FFA) in plasma can increase with the increase of TG levels, thereby promoting the development of obesity-related IR and CVD 33 .”
BackgroundPetrus, P., Bialešová, L., Checa, A., Kerr, A. G., Naz, S., Bäckdahl, J., Gracia, A., Toft, S., Dahlman‐Wright, K., Hedén, P., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01382 · Cited by 50
Silva, G., Ferraresi, C., Almeida, R. T., Motta, M. L., Paixão, T., Ottone, V. O., Fonseca, I. A. T., Oliveira, M. X., Rocha‐Vieira, E., Dias‐Peixoto, M. F., et al. (2017) · Lasers in Medical Science · doi:10.1007/s10103-017-2408-2 · Cited by 56
“mulation of intracellular fat followed by increases in fatty acid metabolites play a role in the development of insulin resistance [4].”
BackgroundCarper, D., Coué, M., Nascimento, E. B. M., Barquissau, V., Lagarde, D., Pestourie, C., Laurens, C., Vily‐Petit, J., Soty, M., Monbrun, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108075 · Cited by 50
Lucas, E., Vila‐Bedmar, R., Arcones, A. C., Cruces‐Sande, M., Cachofeiro, V., Mayor, F., & Murga, C. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0474-6 · Cited by 54
“Interestingly, intra-myocellular lipid content appears to better predict muscle insulin resistance than fat mass in lean individuals and non-obese, non-diabetic but insulin-resistant adults and children (see references in [14]).”
BackgroundCaimari, A., Bas-Prior, J. M. D., Boqué, N., Crescenti, A., Puiggròs, F., Chenoll, E., Martorell, P., Ramón, D., Genovés, S., & Arola, L. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.09.029 · Cited by 52
Buscemi, S., Corleo, D., Vasto, S., Buscemi, C., Massenti, M. F., Nuzzo, D., Lucisano, G., Barile, A. M., Rosafio, G., Maniaci, V., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.255 · Cited by 52
Reichenbach, A., Stark, R., Méquinion, M., Denis, R., Goularte, J. F., Clarke, R., Lockie, S. H., Lemus, M. B., Kowalski, G. M., Bruce, C. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.067 · Cited by 53
“Importantly, gluconeogenesis from glycerol requires a constant rate of glycerol supply (Samuel and Shulman, 2016), and we observed significantly greater TG concentrations in the liver and plasma NEFA in fasted KO mice, a phenomenon also witnessed in AgRP-ablated mice (Joly-Amado et al., 2012).”
Background
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.